AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok.
Human immunodeficiency virus (HIV) seroconversion was studied in a group of 173 injection drug users in Bangkok, Thailand, who had been previously tested for HIV and were interviewed and retested in the fall of 1989. Ten percent of the group had seroconverted. Two factors protected against HIV seroconversion: having stopped sharing injection equipment in response to the acquired immunodeficiency syndrome (AIDS) and having a regular sexual partner. The association between self-reported deliberate risk reduction and reduced HIV seroconversion among persons continuing to inject illicit drugs indicates that injection drug users can change their behavior in response to AIDS and will accurately report on the behavior change, and that the changes can protect against HIV infection.
Des Jarlais
D C
DC
Beth Israel Medical Center, New York, NY.
Choopanya
K
K
Vanichseni
S
S
Plangsringarm
K
K
Sonchai
W
W
Carballo
M
M
Friedmann
P
P
Friedman
S R
SR
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control* / Q000523:psychology; D005260:Female; D006679:HIV Seropositivity / Q000523:psychology*; D006266:Health Education; D006801:Humans; D016015:Logistic Models; D008297:Male; D016485:Needle Sharing; D012309:Risk-Taking; D012725:Sexual Behavior; D012747:Sexual Partners; D015819:Substance Abuse, Intravenous / Q000523:psychology*; D013785:Thailand